Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell Carcinoma
Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell Carcinoma
Recruiting · NCT07097935 · Registry updated 2025-08-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell Carcinoma | Advanced Clear Cell Renal Cell Carcinoma | Recruiting | Phase 1 / Phase 2 | 2025-08-01 | NCT07097935 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | 59 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 208 |